Evidence map›Paper›PMID 31018840›Full record

ArticleBMC health services research2019

Developing a toolkit to implement the Statin Choice Conversation Aid at scale: application of a work reduction model.

Aaron L Leppin, Kasey R Boehmer, Megan E Branda, Nilay D Shah, Ian Hargraves, Sara Dick, Glyn Elwyn, Henry H Ting, Siqin Ye, Ryan Gilles and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT02375815. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02375815 nacompleted

The Statin Choice Implementation Project: Phase 1

Ran2015Enrolled313Registered outcomes1Posted comparisons0ConditionsCardiovascular Factor RiskArmsStatin Choice Implementation
Open the trial in the graph
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Association between Exposure to Statin Choice and Adherence to Statins: An Observational Cohort Study.Medical decision making : an international journal of the Society for Medical Decision Making · 2025
    Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Aaron L LeppinDivision of Health Care Policy and Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Leppin.aaron@mayo.edu.ORCID http://orcid.org/0000-0002-2468-5919
Kasey R BoehmerKnowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Megan E BrandaDepartment of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Nilay D ShahDivision of Health Care Policy and Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Ian HargravesKnowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Sara DickKnowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Glyn ElwynThe Dartmouth Institute for Health Policy and Clinical Practice, Level 5, Williamson Translational Research Building, 1 Medical Center Drive, Labanon, NH, 03756, USA.
Henry H TingDepartment of Cardiovascular Diseases, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Siqin YeDepartment of Medicine, Columbia University Medical Center, 622 West 168th Street, New York, NY, 10033, USA.
Ryan GillesDepartment of Family Medicine, Kootenai Health, 2003 Kootenai Health Way, Coeur d'Alene, ID, 83814, USA.
Marghoob AbbasMosaic Life Care, 5325 Faraon Street, St. Joseph, MO, 64506, USA.
Alex AlexanderKnowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Victor M MontoriKnowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Patient health information preference and statin therapyK23HL121144 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI YE, SIQIN · 2014 to 2018
$784k
National Center for Advancing Translational Sciences UL1 TR000135National Heart, Lung, and Blood Institute K23 HL121144NCATS NIH HHS UL1 TR000135NHLBI NIH HHS K23 HL121144
6 · The paper itself

Abstract

backgroundGuidelines recommend shared decision making (SDM) for determining whether to use statins to prevent cardiovascular events in at-risk patients. We sought to develop a toolkit to facilitate the cross-organizational spread and scale of a SDM intervention called the Statin Choice Conversation Aid (SCCA) by (i) assessing the work stakeholders must do to implement the tool; and (ii) orienting the resulting toolkit's components to communicate and mitigate this work.

methodsWe conducted multi-level and mixed methods (survey, interview, observation, focus group) characterizations of the contexts of 3 health systems (n = 86, 84, and 26 primary care clinicians) as they pertained to the impending implementation of the SCCA. We merged the data within implementation outcome domains of feasibility, appropriateness, and acceptability. Using Normalization Process Theory, we then characterized and categorized the work stakeholders did to implement the tool. We used clinician surveys and IP address-based tracking to calculate SCCA usage over time and judged how stakeholder effort was allocated to influence outcomes at 6 and 18 months. After assessing the types and impact of the work, we developed a multi-component toolkit.

resultsAt baseline, the three contexts differed regarding feasibility, acceptability, and appropriateness of implementation. The work of adopting the tool was allocated across many strategies in complex and interdependent ways to optimize these domains. The two systems that allocated the work strategically had higher uptake (5.2 and 2.9 vs. 1.1 uses per clinician per month at 6 months; 3.8 and 2.1 vs. 0.4 at 18 months, respectively) than the system that did not. The resulting toolkit included context self-assessments intended to guide stakeholders in considering the early work of SCCA implementation; and webinars, EMR integration guides, video demonstrations, and an implementation team manual aimed at supporting this work.

conclusionsWe developed a multi-component toolkit for facilitating the scale-up and spread of a tool to promote SDM across clinical settings. The theory-based approach we employed aimed to distinguish systems primed for adoption and support the work they must do to achieve implementation. Our approach may have value in orienting the development of multi-component toolkits and other strategies aimed at facilitating the efficient scale up of interventions.

trial registrationClinicalTrials.gov NCT02375815 .

Indexed as

Decision MakingDecision Support TechniquesPatient ParticipationCommunicationFeasibility StudiesFocus GroupsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInterviews as TopicPhysicians, Primary CareSurveys and QuestionnairesHydroxymethylglutaryl-CoA Reductase InhibitorsImplementationImplementation strategiesImplementation toolkitScale-upShared decision makingSpreadStatin choice conversation aidStatin choice decision aidStatins

Identifiers

PMID31018840
PMCPMC6480421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.